Cirsium Biosciences Presents Novel Plant-Based AAV Production Platform at Neuroscience 2024

Overview

Cirsium Biosciences recently presented at Neuroscience 2024 in Chicago, Illinois. Our presentation, titled “Efficient, Safe, and Cost-Effective Production of Potent AAV Vectors Using Whole Plants as Bioreactors,” showcased our innovative approach to gene therapy manufacturing. We highlighted how Cirsium leverages whole plants as bioreactors to produce potent AAV vectors, focusing on enhancing efficiency, safety, and reducing production costs. This method makes gene therapies more accessible and scalable for a broader range of applications.

Presentation Highlights

1. Gene Therapy Manufacturing Industry Challenges
   Outlined the current limitations in traditional gene therapy production, including high costs, scalability issues, and safety concerns.
   
   
2. Cirsium’s Plant-Based Solution & Data
   Our solution uses whole plants as natural bioreactors, offering a sustainable and cost-effective alternative. The presentation included data demonstrating our success in improving efficiency and maintaining safety standards, positioning our approach as a viable pathway for the future of gene therapy.

Access Our Conference Presentation

Enter your information below to access the download link for the full presentation.

Privacy Note: We respect your privacy and will not share your email address. You can unsubscribe from our communications at any time.